Kaposi sarcoma care and research partnership in Zambia and Tanzania
Kaposi Sarcoma in the Era of ART in Africa Program (KEAAP)
This program connects hospitals in Zambia, Tanzania, and the U.S. to improve how Kaposi sarcoma is found, treated, and understood in people living with HIV on antiretroviral therapy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lsu Health Sciences Center NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project ID | NIH-11412991 on NIH RePORTER |
What this research studies
From a patient viewpoint, this program builds a network between cancer hospitals in Zambia and Tanzania and a U.S. cancer center to do clinical and laboratory work on Kaposi sarcoma (KS). Teams will work on better ways to detect KS, follow patient care and outcomes, and study how the disease develops and how the immune system responds. The program also aims to strengthen local research and clinical capacity so care can be improved where patients live. Research activities may include collecting clinical data, tissue samples, and linking lab findings to patient care improvements.
Who could benefit from this research
Good fit: People living with HIV in Zambia or Tanzania who have or are at risk for Kaposi sarcoma, including those receiving antiretroviral therapy, would be the most likely candidates to take part.
Not a fit: People without HIV, patients living outside the study regions, or those with unrelated health conditions are unlikely to see direct benefit from this program.
Why it matters
Potential benefit: If successful, this program could lead to earlier diagnosis, better treatment options, and fewer deaths from Kaposi sarcoma for people living with HIV in the participating countries.
How similar studies have performed: Previous integrated HIV–cancer programs in the region have improved KS diagnosis and care, but multi-country efforts linking lab science to patient outcomes at this scale remain limited.
Where this research is happening
New Orleans, United States
- Lsu Health Sciences Center — New Orleans, United States (Active)
Researchers
- Principal investigator: Wood, Charles — Lsu Health Sciences Center
- Study coordinator: Wood, Charles
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.